Company / Shares Outstanding
NovaBay Pharmaceuticals, Inc. Shares Outstanding History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
4.9M
FY2024
5-year range
2.0M / 43.7M
FY2020-FY2024
Trend
-56.5%
vs FY2023
Sector context
#208 of 212
Health Care
What the data says
Among 212 Health Care companies, NovaBay Pharmaceuticals, Inc. is in the top 2% for shares outstanding. Shares Outstanding has fluctuated over the past 10 years, ranging from 2035000.00 in FY2022 to 43657000.00 in FY2021.
Based on SEC 10-K filings.
4885000.00 in FY2024 with a 5-year CAGR of -25.7%.
Increased from 2035000.00 to 4885000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -51.8%
- 5-Year CAGR
- -25.7%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 212This company 4.9M Sector average 306.3M
▼
-98.4% below sector average
Key checks
Key Insights
- In FY2024, shares outstanding decreased 56.5% year-over-year.
- Ranks #208 out of 212 companies in the Health Care sector.
- Peak shares outstanding was recorded in FY2021.
- Lowest shares outstanding in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 4.9M | -56.5% |
| FY2023 | 11.2M | +451.8% |
| FY2022 | 2.0M | -95.3% |
| FY2021 | 43.7M | +24.5% |
| FY2020 | 35.1M | +62.1% |
| FY2019 | 21.6M | +26.9% |
| FY2018 | 17.1M | +11.7% |
| FY2017 | 15.3M | +338.0% |
| FY2016 | 3.5M | +68.7% |
| FY2015 | 2.1M | -95.4% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026